https://www.selleckchem.com/MEK.html
2 vs. 1.4 years, p less then 0.0001) and in PFS (2.1 vs. 0.3 years, p less then 0.0001). R-ESHAP is an effective treatment in relapsed FL patients who respond to the previous line and has to be considered as an adequate alternative for some patients.Multi-drug resistance is a major issue faced by the global pharmaceutical industry. Short antimicrobial peptides such as anoplins can be used to replace antibiotics, thus mitigating this issue. Antimicrobial activity, non-toxicity, and structural stability are essential features of a therapeutic drug. An
Like
Comment
Share
